Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pedrol

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
HIV Medicine|August 5, 2015
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX studyE Pedrol, J M Llibre, M Tasias, et al.
Medicina Clinica|October 13, 1990
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]J M González-Clemente, J M Miró, E Pedrol, et al.
AIDS (London, England)|June 1, 1990
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapyE Pedrol, J M González-Clemente, J M Gatell, et al.
HIV Clinical Trials|July 13, 2004
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)A Casado, X Badia, E Consiglio, et al.
HIV Clinical Trials|May 14, 2008
Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced diseaseF Pulido, M A Del Pozo, M Fernández-Guerrero, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicityC Morén, M Bañó, I González-Casacuberta, et al.
HIV Clinical Trials|March 11, 2011
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant statusJ A Pérez-Molina, I Suárez-Lozano, A Del Arco, et al.
Revista Clinica Espanola|October 5, 2007
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patientsJ Mallolas, J L Blanco, J Pich, et al.
Antiviral Research|November 28, 2009
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study)P Echeverría, E Negredo, G Carosi, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
HIV Medicine|August 5, 2015
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX studyE Pedrol, J M Llibre, M Tasias, et al.
Medicina Clinica|October 13, 1990
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases]J M González-Clemente, J M Miró, E Pedrol, et al.
AIDS (London, England)|June 1, 1990
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapyE Pedrol, J M González-Clemente, J M Gatell, et al.
HIV Clinical Trials|July 13, 2004
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)A Casado, X Badia, E Consiglio, et al.
HIV Clinical Trials|May 14, 2008
Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced diseaseF Pulido, M A Del Pozo, M Fernández-Guerrero, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2015
Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicityC Morén, M Bañó, I González-Casacuberta, et al.
HIV Clinical Trials|March 11, 2011
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant statusJ A Pérez-Molina, I Suárez-Lozano, A Del Arco, et al.
Revista Clinica Espanola|October 5, 2007
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patientsJ Mallolas, J L Blanco, J Pich, et al.
Antiviral Research|November 28, 2009
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study)P Echeverría, E Negredo, G Carosi, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
Pageof 8